This inventor holds 1 USPTO granted patent. Top assignees: Boston University, Sri International. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 833 
1 out of 1,361 
Years Active: 2018
Title: Wenyu Wang: Innovator in Hepatitis C Research
Introduction
Wenyu Wang is a notable inventor based in Boston, MA, who has made significant contributions to the field of medical research. He holds a patent for a groundbreaking invention that targets the hepatitis C virus (HCV). His work has implications for improving treatment options for patients affected by this virus.
Latest Patents
Wenyu Wang's patent, titled "Aglaroxin C and derivatives as HCV entry inhibitors," focuses on a rocaglamide or a rocaglate derivative, particularly aglaroxin C. This compound has been shown to block hepatitis C virus entry with improved potency and therapeutic index. This innovation represents a promising advancement in the fight against HCV.
Career Highlights
Throughout his career, Wenyu Wang has worked with esteemed organizations such as SRI International and Boston University. His experience in these institutions has allowed him to develop and refine his research, leading to impactful innovations in the medical field.
Collaborations
Wenyu Wang has collaborated with notable colleagues, including Tony Tianyi Wang and Shufeng Liu. These partnerships have contributed to the advancement of his research and the development of his patented inventions.
Conclusion
Wenyu Wang's contributions to hepatitis C research through his innovative patent highlight his role as a significant inventor in the medical field. His work continues to pave the way for new therapeutic options for patients suffering from HCV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile